BioSpace News Archive

Clearside Biomedical, Inc. announced that its fourth quarter and full year 2023 financial results will be reported on Tuesday, March 12, 2024 after the close of the financial markets.

Amarin Corporation plc, announced financial results for the quarter and year ended December 31, 2023 and provided an update on the Company’s operations.

Chimerix reported financial results for the fourth quarter and full-year ended December 31, 2023 and provided an operational update.

Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced preliminary unaudited fourth quarter and full-year 2023 net revenues.

ASLAN Pharmaceuticals Ltd. (Nasdaq: ASLN) today announced it has received a favorable patentability opinion from the European Patent Office (EPO) acting as the International Examiner on a polymorph patent application for farudodstat which, if granted in the national stages, will extend effective patent protection for farudodstat until at least 2043.

GH Research PLC, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, reported financial results for the year ended December 31, 2023, and provided updates on its business.

Neurenati Therapeutics is delighted to announce the successful closing of its seed funding round, securing 1.2 million $ from Genson Capital, on the 2024 Rare Disease Day.

Laser Photonics Corporation announced that it received an order from Pima Air & Space Museum for its CleanTech LPC-1000-CTHS laser cleaning system.

TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav ® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors.

Moderna, Inc. (NASDAQ:MRNA) today announced that it will host its fifth annual Investor Event focused on vaccines and business updates on Wednesday, March 27, 2024.